Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items published in 2009

There are 1996 items in the Healthy Skepticism Library that were published in 2009.

Page 20 of 20 pages ‹ First  < 18 19 20

Olver IN, Haines IE.
What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century?
eMJA 2009; 190:(2):74-77

Loukas E.
Sales Through Retail Pharmacies (Twelve months to November 2008*)
IMS 2009

Sweet M.
Pharmaceutical marketing and the internet
Australian Prescriber 2009; 23:2-4

Stockigt JR.
The quality of medication information in Australia: the need for more clinical expertise and accountability
eMJA 2009; 190:(3):110-111

Mansell P, Read J.
Posttraumatic stress disorder, drug companies, and the internet.
J Trauma Dissociation 2009; 10:(1):9-23

Alkhateeb FM, Khanfar NM, Clauson KA.
Characteristics of physicians who frequently see pharmaceutical sales representatives.
J Hosp Mark Public Relations 2009; 19:(1):2-14

Polen HH, Khanfar NM, Clauson KA.
Impact of Direct-to-Consumer Advertising (DTCA) on Patient Health-Related Behaviors and Issues.
Health Mark Q. 2009; 26:(1):42-55

Elshaug AG, Moss JR, Littlejohns P, Karnon J, Merlin TL, Hiller JE.
Identifying existing health care services that do not provide value for money
Med J Aust 2009; 190:(5):269-273

Pharma 2020: Marketing the future: Which path will you take?
: PriceWaterhouseCoopers 2009

Aronson JK, Price D, Ferner RE
A strategy for regulatory action when new adverse effects of a licensed product emerge.
Drug Saf 2009; 32:(2):91-8

Leo J, Lacasse JR.
Consumer advertisements of medications for ADHD
Tamimi S, Leo J. Rethinking ADD: From Brain To Culture. New York: Palgrave Macmillan 2009

Abelson J, Collins PA.
Media Hyping and the 'Herceptin Access Story': An Analysis of Canadian and UK Newspaper Coverage
Healthcare Policy / Politiques de Santé 2009; 4:(3):e113-e128

Mulki JP, Jaramillo JF, Locander WB.
Critical Role of Leadership on Ethical Climate and Salesperson Behaviors
Journal of Business Ethics 2009; (86):125-141

Jureidini J
How do we Safely Treat Depression in Children, Adolescents and Young Adults?
Drug Saf 2009; 32:(4):275-82

Rod M, Saunders S.
The informative and persuasive components of pharmaceutical
International Journal of Advertising 2009; 28:(2):313-349

Manhattan Research
The Absolute, Relative, and Incremental ROI of DTC Digital Marketing
: Manhattan Research 2009

Molnar FJ, Man-son-hing M, Hutton B, Fergusson DA.
Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review
Open Medicine 2009; 3:(2):

Altman DG.
Missing outcomes in randomized trials: addressing the dilemma
Open Medicine 2009; 3:(2):

Food and Drug Administration
RE: NDA #20-449 Taxotere® (docetaxel) Injection Concentrate, Intravenous Infusion (IV)
: Food and Drug Administration 2009

Jureidini JN, McHenry LB.
Key Opinion Leaders and Paediatric Antidepressant Overprescribing
Psychotherapy and Psychosomatics 2009; 78:(4):197-201

Vandereycken W.
[An analysis of advertisements for psychotropic drugs in the Dutch Journal of Psychiatry ('Tijdschrift voor Psychiatrie')].
Tijdschr Psychiatr. 2009; 51:(6):407-11

Greene JA, Podolsky SH
Keeping modern in medicine: pharmaceutical promotion and physician education in postwar america.
Bull Hist Med 2009; 83:(2):331-77

Liang BA, Mackey T.
Searching for safety: addressing search engine, website, and provider accountability for illicit online drug sales.
Am J Law Med. 2009; 35:(1):125-84

Rojas M.
Price discrimination by pharmaceutical companies across Central American countries
International Journal of Pharmaceutical and Healthcare Marketing 2009; 3:(2):118 - 136

Kalyanaram GK.
The endogenous modeling of the effect of direct-to-consumer advertising in prescription drugs
International Journal of Pharmaceutical and Healthcare Marketing 2009; 3:(2):137 - 148

Greenland S.
Accounting for uncertainty about investigator bias: disclosure is informative: How could disclosure of interests work better in medicine, epidemiology and public health?
Journal of Epidemiology and Community Health 2009; 63:593-598

Michaels D.
Addressing conflict in strategic literature reviews: disclosure is not enough: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:599-600

Weed DL.
Conflicts of interest: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:(8):601-602

Spelsberg A, Martiny A, Schoenhoefer PS.
Is disclosure of potential conflicts of interest in medicine and public health sufficient to increase transparency and decrease corruption?: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:(8):603-605

Wagner W, McGarity T.
Regulatory reinforcement of journal conflict of interest disclosures: How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:(8):606-607

Marcovitch H.
How do potential conflicts of interest confuse medicine and public health? How could disclosure of interests work better in medicine, epidemiology and public health?
J Epidemiol Community Health 2009; 63:(8):608-609

12th Annual Survey on Consumer Reaction to DTC Advertising of Prescription Drugs Reveals: Nearly 50% of Online Consumers Report Health Videos a Top Resource
Pharma Live 2009

Bove AA.
President's Page: Relations With Industry: Thoughts on Claims of a Broken System
J Am Coll Cardiol 2009; 54:(2):177-179

O'Meara A.
Chasing Medical Miracles - The Promise and Perils of Clinical Trials
: Walker Books 2009

Glasziou PP.
Promoting evidence-based non-drug interventions: time for a non-pharmacopoeia?
MJA 2009; 191:(2):52-53

Lexchin J.
CJEM and pharmaceutical advertisements: it’s time for an end
CJEM 2009; 11:(4):375-9

Limbu Y, Torres IM.
The effects of involvement and ad type on attitudes toward direct-to-consumer advertising of prescription drugs.
J Health Hum Serv Adm 2009 Sum; 32:(1):107-38

Rutherford BR, Sneed JR, Roose SP.
Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials.
Psychother Psychosom 2009; 78:(3):172-81

Kale SA, Barkin RL.
Resuscitation and rescue of the pharmaceutical detail: a prescriber-drug representative collaboration.
Compr Ther 2009 Sum; 35:(2):68-71

Martin JH, Beer C, Morris RG, Doogue MP.
Doctors and the pharmaceutical industry: time for a national policy?
MJA 2009; 191:(3):189-190

Taylor D
Branding Q&A
MedAdNews 2009

Wyeth Ghostwriting Archive
PLoS Med 2009;

Gérvas J, Mansfield PR
Physicians, the industry and population health
Journal of Epidemiology and Community Health 2009; 63:(10):773-774

Van Der Weyden MB
Confronting conflict of interest
eMJA 2009; 191:(5):241

Gülöksüz S, Oral ET, Ulaş H.
[Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
Turk Psikiyatri Derg 2009; 20:(3):236-42

Tipton M, Bharadwaj S, Robertson D
Regulatory Exposure of Deceptive Marketing and its Impact on Firm Value
Journal of Marketing 2009;

Kalb PE, Greenberg PE.
Legal and economic perspectives concerning US government investigations of alleged off-label promotion by drug manufacturers.
Pharmacoeconomics 2009; 27:(8):623-5

Egilman D
Just say no
BMJ 2009; 339:b4527

Zinner DE, Bjankovic D, Clarridge B, Blumenthal D, Campbell EG
Participation Of Academic Scientists In Relationships With Industry
Health Affairs 2009; 28:(6):1814

Evidence and Recommendations for a Model PharmFree Curriculum
PharmFree 2009

de Barros JA
Medicamentos: una contribución a la reflexión  hacia su uso racional
RISAI 2009; 1:(3):1-5

Ghaemi SN
The failure to know what isn't known: negative publication bias with lamotrigine and a glimpse inside peer review
Evid Based Mental Health 2009; 12:(3):65

The Royal Australian and New Zealand College of Psychiatrists
Symposium on Commercial Sponsorship of Psychiatrist Education

Sweet MA, Simons MJ
As mass media evolves into 'masses of media', what are the implications for our health?
Med J Aust 2009; 191:(11/12):618-619

Chapman S, Holding SJ, Ellerm J, Heenan RC, Fogarty AS, Imison M, Mackenzie R, McGeechan K
The content and structure of Australian television reportage on health and medicine, 2005-2009: parameters to guide health workers
Med J Aust 2009; 191:(11/12):620-624

Medicines Australia Code of Conduct: breaches
Aust Prescr 2009

Archontaki M, Symvoulakis EK, Hajiioannou JK, Stamou AK, Kastrinakis S, Bizaki AJ, Kyrmizakis DE.
Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants.
B-ENT 2009; 5:(3):159-62

Sismondo S, Nicholson SH.
Publication planning 101.
J Pharm Pharm Sci 2009; 12:(3):273-9

Idris KM, Yousif MA, Mustafa AF
Influence of pharmaceutical industry's promotion on the doctors' prescribing patterns in Sudan
The Journal of Medicine Use in Developing Countries 2009; 1:(3):3- 13

Ball JG, Liang A, Lee WN.
Representation of African Americans in direct-to-consumer pharmaceutical commercials: a content analysis with implications for health disparities.
Health Mark Q 2009; 26:(4):372-90

Fogel J, Novick D.
Direct-to-consumer advertisements of prescription medications over the Internet.
Health Mark Q 2009; 26:(4):347-71

Bhutada NS, Cook CL, Perri M 3rd.
Consumers responses to coupons in direct-to-consumer advertising of prescription drugs.
Health Mark Q 2009; 26:(4):333-46

DeLorme DE, Huh J, Reid LN.
Direct-to-consumer advertising skepticism and the use and perceived usefulness of prescription drug information sources.
Health Mark Q 2009; 26:(4):293-314

Silver LS, Stevens RE, Loudon D.
Direct-to-consumer advertising of pharmaceuticals: concepts, issues, and research.
Health Mark Q 2009; 26:(4):251-8

Smith BD
An exploratory study of key opinion leadership management trends among European pharmaceutical companies
Journal of Medical Marketing 2009; 9:(4):291–300

Michael Stros, Juerg Hari, John Marriott
The relevance of marketing activities in the Swiss prescription drugs market: Two empirical qualitative studies
International Journal of Pharmaceutical and Healthcare Marketing 2009; 3:(4):323 - 346

Goldacre B
Bad Science : HarperCollins 2009

Villanueva T
Centro Vasco de Información de Medicamentos CEVIME-MIEZ
Rev Port Clin Geral 2009; 25:724 contenidos/informacion/presentacion_cevime/ es_1219/indice_c.html

Fava GA
The Decline of Pharmaceutical Psychiatry and the Increasing Role of Psychological Medicine
Psychother Psychosom 2009; 78:(4):220-227

Nelson DE, Hesse BW, Croyle RT
Making Data Talk: Communicating Public Health Data to the Public, Policy Makers, and the Press : Oxford University Press 2009

Herzberg D.
'Will wonder drugs never cease!': a prehistory of direct-to-consumer advertising.
Pharm Hist 2009; 51:(2):47-56

Bunniran S, McCaffrey DJ 3rd, Bentley JP, Bouldin AS.
Pharmaceutical product withdrawal: attributions of blame and its impact on trust.
Res Social Adm Pharm 2009; 5:(3):262-73

Young T
Death by Prescription Toronto: Key Porter Books 2009

Moynihan R
Drug Safety: Battle over popular bone drug Fosamax bursts into court
BMJ 2009 08 06;

Exorcising authors
The Finanical Times 2009 08 30

Bextra Whistleblower Case Started Investigation of Pfizer
Reuters 2009 09 02

Parsai G
Modify the pill advertisements, Drug Controller asks manufacturers
The Hindu 2009 09 09

Williams SJ, Gabe J, Davis P
Pharmaceuticals and Society: Critical Discourses and Debates : Wiley-Blackwell 2009,descCd-description.html

Hutton D
Whistleblowing at Health Canada: Chopra speaks out
CMAJ 2009 09 15; 181:(6-7):

PharmaTimes Great Oxford Debate - 2009
Pharma Times 2009

Sawaya L
The Persuasion Report Orleans, Canada: Reticulum 2009

Issues and Challenges Related to Local Television: Report of the Standing Committee on Canadian Heritage
: House of Commons, Canada 2009 Jun

Krimsky S, Sweet E
An Analysis of Toxicology and Medical Journal Conflict-of-Interest Polices
Accountability in Research 2009; 16:(5):235 - 253

Evaluating evolving sales models & advanced technology for a customer centric approach
Pharmaceutical Sales Force Effectiveness Strategies 2009 Aug

Anvisa não pode regulamentar publicidade, diz juiz
Consultor Jurídico 2009 10 23

Perrone M
GAO: FDA fails to follow up on unproven drugs
Yahoo News 2009 10 26

FDA Needs to Enhance Its Oversight of Drugs Approved on the Basis of Surrogate Endpoints
United States Government Accountability Office 2009 Sep

Dunn A
Best Strategic Learning Investment in 2010?
Hoenig Carlson E Courtney Justice, The Cournell Group 2009 Dec

Haag D
rapport in het kader van algemeen toezicht naar aanleiding van het onderzoek bij Sanofi Pasteur MSD naar het geneesmiddel Gardasil (Report about Sanofi)
Staatstoezicht Op De Volksgezondheid 2009 July

Haag D
Rapport in het kader van algemeen toezicht naar annleiding van het onderzoek bij GSK naar geneesmiddel Cervarix
Staatstoezicht Op De Volksgezondheid 2009 July

Herzberg D.
'Will wonder drugs never cease!': a prehistory of direct-to-consumer advertising.
Pharm Hist 2009; 51:(2):47-56

Karlowicz KA.
Direct-to-consumer advertising for erectile dysfunction drugs.
Urol Nurs 2009; 29:(4):214

Stell LK.
Drug reps off campus! Promoting professional purity by suppressing commercial speech.
J Law Med Ethics 2009; 37:(3):431-43,

Tamimi NA, Ellis P.
Drug development: from concept to marketing!
Nephron Clin Pract. 2009; 113:(3):c125-31

Rothman DJ, McDonald WJ, Berkowitz CD, Chimonas SC, DeAngelis CD, Hale RW, Nissen SE, Osborn JE, Scully JH Jr, Thomson GE, Wofsy D.
Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.
JAMA 2009 1; 301:(13):1367-72

Jutel A, Menkes DB.
'But doctors do it...': nurses' views of gifts and information from the pharmaceutical industry
Ann Pharmacother. 2009; 43:(6):1057-63

Page 20 of 20 pages ‹ First  < 18 19 20


  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Click to Register

(read more)

Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others.